Cargando…
Piceatannol, a Dietary Polyphenol, Alleviates Adipose Tissue Loss in Pre-Clinical Model of Cancer-Associated Cachexia via Lipolysis Inhibition
Cancer-associated cachexia (CAC) is the nutrition-independent loss of lean muscle and adipose tissues, and results in reduced chemotherapy effectiveness and increased mortality. Preventing adipose loss is considered a key target in the early stages of cachexia. Lipolysis is considered the central dr...
Autores principales: | Kershaw, Jonathan C., Elzey, Bennett D., Guo, Xiao-Xuan, Kim, Kee-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183120/ https://www.ncbi.nlm.nih.gov/pubmed/35684106 http://dx.doi.org/10.3390/nu14112306 |
Ejemplares similares
-
Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning
por: Han, Jun, et al.
Publicado: (2018) -
Piceatannol Prevents Obesity and Fat Accumulation Caused by Estrogen Deficiency in Female Mice by Promoting Lipolysis
por: Arisawa, Kotoko, et al.
Publicado: (2023) -
Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue
por: Park, Sujeong, et al.
Publicado: (2021) -
The Molecular Brakes of Adipose Tissue Lipolysis
por: Li, Yongguo, et al.
Publicado: (2022) -
Repurposing of Antibiotic Sulfisoxazole Inhibits Lipolysis in Pre-Clinical Model of Cancer-Associated Cachexia
por: Chitti, Sai V., et al.
Publicado: (2021)